{"id":"W2807161544","doi":"10.1093/jnci/djy094","title":"Adjuvant Anti-HER2 Therapy, Treatment-Related Amenorrhea, and Survival in Premenopausal HER2-Positive Early Breast Cancer Patients","year":2018,"lang":"en","type":"article","venue":"JNCI Journal of the National Cancer Institute","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":104,"is_retracted":false,"has_abstract":true,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto","funders":"National Cancer Institute; Genentech; Novartis Pharma; Astellas Pharma; European Society for Medical Oncology; Alliance for Clinical Trials in Oncology Foundation; Teva Pharmaceutical Industries; Novartis; GlaxoSmithKline; Eli Lilly and Company","keywords":"Lapatinib; Trastuzumab; Medicine; Oncology; Internal medicine; Hazard ratio; Breast cancer; Interquartile range; Cohort; Gynecology; Cancer; Confidence interval","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005106314,0.0002315525,0.0004487739,0.0002510472,0.0001791861,0.00005001849,0.0002508935,0.0001190077,0.0003251678],"category_scores_gemma":[0.00008862479,0.000147318,0.0001055014,0.000530956,0.000437405,0.0003783706,0.00006626685,0.0004641899,0.000008238199],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002213713,"about_ca_system_score_gemma":0.002059804,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004208021,"about_ca_topic_score_gemma":0.001999478,"domain_scores_codex":[0.9972242,0.0001560542,0.0005990957,0.0002592586,0.001414639,0.0003467654],"domain_scores_gemma":[0.9974962,0.00006888722,0.0003809979,0.0001314963,0.001730295,0.0001920501],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002516891,0.000865308,0.9522266,0.00003669314,0.0007576423,0.00003999213,0.001853193,0.000212815,0.005122789,0.0001291118,0.001832076,0.03440693],"study_design_scores_gemma":[0.007148412,0.001360082,0.9811789,0.0006410975,0.0000749995,0.0001057296,0.0000261267,0.0000855992,0.002753208,0.00014165,0.006328623,0.0001555261],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9901683,0.001178552,0.000002835053,0.004111405,0.002216936,0.0005783118,0.0003263426,0.000008999466,0.001408368],"genre_scores_gemma":[0.9956139,0.001953117,0.00004753419,0.000491134,0.00128997,0.00003774952,0.000006919973,0.0000301654,0.0005295488],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03425141,"threshold_uncertainty_score":0.6361297,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05072946608820937,"score_gpt":0.37832727657369,"score_spread":0.3275978104854806,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}